Fmr LLC Allovir, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Allovir, Inc. stock. As of the latest transaction made, Fmr LLC holds 308,860 shares of ALVR stock, worth $293,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,860

Previous 271,837 13.62%

Holding current value

$293,417

Previous $206,000 7.77%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.72 - $0.82 $26,656 - $30,358	37,023 Added 13.62%	308,860 $222,000
Q1 2024 May 13, 2024	SELL	$0.64 - $0.78 $3.47 Million - $4.23 Million	-5,420,945 Reduced 95.22%	271,837 $206,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $2.39 $2.71 Million - $9.54 Million	-3,989,678 Reduced 41.21%	5,692,782 $3.87 Million
Q3 2023 Nov 13, 2023	BUY	$2.15 - $3.64 $345,973 - $585,741	160,918 Added 1.69%	9,682,460 $20.8 Million
Q2 2023 Aug 11, 2023	BUY	$3.17 - $5.82 $6.82 Million - $12.5 Million	2,151,913 Added 29.2%	9,521,542 $32.4 Million
Q1 2023 May 11, 2023	BUY	$3.94 - $7.05 $1.27 Million - $2.28 Million	323,256 Added 4.59%	7,369,629 $29 Million
Q4 2022 Feb 13, 2023	SELL	$4.7 - $9.98 $1.13 Million - $2.39 Million	-239,463 Reduced 3.29%	7,046,373 $36.1 Million
Q3 2022 Nov 10, 2022	BUY	$4.13 - $8.79 $404,541 - $860,998	97,952 Added 1.36%	7,285,836 $57.5 Million
Q2 2022 Aug 12, 2022	SELL	$3.26 - $7.06 $2.44 Million - $5.29 Million	-748,646 Reduced 9.43%	7,187,884 $28 Million
Q1 2022 May 13, 2022	BUY	$6.75 - $13.52 $3.75 Million - $7.51 Million	555,467 Added 7.53%	7,936,530 $53.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.94 - $25.99 $663,576 - $1.33 Million	51,281 Added 0.7%	7,381,063 $95.5 Million
Q3 2021 Nov 15, 2021	BUY	$16.97 - $25.06 $15 Million - $22.1 Million	883,031 Added 13.7%	7,329,782 $184 Million
Q2 2021 Aug 13, 2021	BUY	$19.44 - $25.06 $125 Million - $162 Million	6,446,751 New	6,446,751 $127 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

46.5M

Call Options Held

201K

Put Options Held

3.1K

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $88.4M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account